Drug-information

Safety and Efficacy of the Pfizer Covid-19 Vaccine
A two-dose regimen of Pfizer vaccine conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. 
Dexamethasone for COVID-19 infection treatment
Dexamethasone : the first life-saving drug for COVID-19 patients Clinical trials make it possible to evaluate whether a treatment improves outcomes. Developing a hypothesis, for example if treatment A is better than standard treatment B, clinical trials enable understanding of the role of an intervention in improving patient care. In the...
Different Type of Coronavirus Vaccine Approaches
Moderna's COVID-19 Vaccine Becomes 2nd To Earn FDA Authorization
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine — this one developed by Moderna for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Authorized Use For the prevention of 2019 coronavir...
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.
FDA Authorizes Baricitinib plus Remdesivir for Treatment of COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical...
FDA Authorizes Baricitinib plus Remdesivir for Treatment of COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical...
FDA Authorizes Baricitinib plus Remdesivir for Treatment of COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical...
mRNA Vaccine - Basis of Pfizer and Moderna COVID-19 vaccines
The basis of upcoming Pfizer and Moderna coronavirus vaccines. How it works?
MORE ABOUT PFIZER AND BIONTECH VACCINE (P2)
  It’s a two-shot vaccine, so what happens if people miss their second shot? Is a single shot still protective? The Pfizer-BioNTech vaccine requires two injections, given 21 days apart, to prime the immune system well enough to fight off the coronavirus. Two shots are needed, and the second shot is required to...